Reaction #164813

ord-9c0c5010c8dc468cac1b68cd317e6b5d

Solvents

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Procedure

7.3 220 mg (1.24 mmol) of 23, 362 mg (1.24 mmol) of 4-chlorobenzyl piperazine-1-carboxylate hydrochloride, 168 mg (1.24 mmol) of 1-hydroxybenzotriazole (HOBt), 143 mg (1.24 mmol) of N-methylmorpholine and 238 mg (1.24 mmol) of 3-dimethylaminopropylcarbodiimide hydrochloride (DAPECI) are stirred at RT for 48 h in 10 ml of DMF.

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08841324B2uspto-grants-2014_09